Evaluating the Potential of Delta Radiomics for Assessing Tyrosine Kinase Inhibitor Treatment Response in Non-Small Cell Lung Cancer Patients

Ting Wei Wang, Heng Sheng Chao, Hwa Yen Chiu, Yi Hui Lin, Hung Chun Chen, Chia Feng Lu, Chien Yi Liao, Yen Lee, Tsu Hui Shiao, Yuh Min Chen, Jing Wen Huang*, Yu Te Wu*

*此作品的通信作者

研究成果: Article同行評審

摘要

Our study aimed to harness the power of CT scans, observed over time, in predicting how lung adenocarcinoma patients might respond to a treatment known as EGFR-TKI. Analyzing scans from 322 advanced stage lung cancer patients, we identified distinct image-based patterns. By integrating these patterns with comprehensive clinical information, such as gene mutations and treatment regimens, our predictive capabilities were significantly enhanced. Interestingly, the precision of these predictions, particularly related to radiomics features, diminished when data from various centers were combined, suggesting that the approach requires standardization across facilities. This novel method offers a potential pathway to anticipate disease progression in lung adenocarcinoma patients treated with EGFR-TKI, laying the groundwork for more personalized treatments. To further validate this approach, extensive studies involving a larger cohort are pivotal.

原文English
文章編號5125
期刊Cancers
15
發行號21
DOIs
出版狀態Published - 11月 2023

指紋

深入研究「Evaluating the Potential of Delta Radiomics for Assessing Tyrosine Kinase Inhibitor Treatment Response in Non-Small Cell Lung Cancer Patients」主題。共同形成了獨特的指紋。

引用此